Quoin Pharmaceuticals, Ltd. (QNRX)
NASDAQ: QNRX · Real-Time Price · USD
5.45
-0.01 (-0.18%)
Apr 28, 2026, 4:00 PM EDT - Market closed
Quoin Pharmaceuticals Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Apr '26 Apr 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Market Capitalization | 10 | 12 | 5 | 5 | 7 | 15 | |
| Market Cap Growth | 204.42% | 127.24% | 10.02% | -29.65% | -54.69% | - | |
| Enterprise Value | -7 | 9 | -2 | -5 | -4 | 21 | |
| Last Close Price | 5.45 | 14.43 | 22.77 | 171.68 | 596.40 | 9555.01 | |
| PB Ratio | 0.62 | 0.92 | 0.58 | 0.86 | 0.93 | 23.12 | |
| P/TBV Ratio | 0.77 | 0.95 | 0.61 | 0.95 | 1.03 | - | |
| Debt / Equity Ratio | 0.18 | 0.18 | 0.32 | 0.62 | 0.56 | 7.19 | |
| Net Debt / Equity Ratio | -1.25 | -1.25 | -1.21 | -1.27 | -1.18 | -4.20 | |
| Net Debt / EBITDA Ratio | 1.01 | 1.01 | 1.18 | 0.77 | 0.95 | 0.46 | |
| Quick Ratio | 3.38 | 3.38 | 3.36 | 2.99 | 3.64 | 1.64 | |
| Current Ratio | 3.61 | 3.61 | 3.57 | 3.15 | 3.79 | 1.79 | |
| Return on Equity (ROE) | -141.59% | -141.59% | -120.55% | -132.92% | -232.68% | - | |
| Return on Assets (ROA) | -56.41% | -56.41% | -42.72% | -44.03% | -48.59% | -70.60% | |
| Return on Capital Employed (ROCE) | -109.70% | -109.70% | -82.70% | -109.20% | -84.70% | -126.80% | |
| Earnings Yield | -160.78% | -130.55% | -168.23% | -179.39% | -136.30% | -141.27% | |
| Buyback Yield / Dilution | -710.69% | -710.69% | -411.86% | - | - | - | |
Source: S&P Capital IQ. Standard template.
Financial Sources.